Clinical Trials Directory

Trials / Completed

CompletedNCT00714311

Efficacy of Transference-Focused Psychotherapy for Borderline Personality Disorder

A Randomized-Controlled Trial of Transference-Focused Psychotherapy vs. Treatment by Experienced Community Psychotherapists for Borderline Personality Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
104 (actual)
Sponsor
University Hospital Muenster · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out whether Transference-Focused Psychotherapy (TFP) is effective in the treatment of Borderline Personality Disorder.

Detailed description

Borderline personality disorder represents a sever clinical condition that affects 1-2% of the community and is characterized by a pervasive instability of interpersonal relationships, self-image, and affects, as well as a marked impulsivity; up to 10% of the patients commit suicide. Transference-Focused Psychotherapy (TFP) is one psychotherapeutic approach among five that have been manualized and evaluated in RCTs. So far, TFP has not been compared to a control condition which is a crucial step in the evaluation of the efficacy of a psychosocial intervention. This study is an RCT that compares one year of outpatient TFP to treatment by experienced community psychotherapists for borderline personality disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTransference-Focused PsychotherapyOutpatient psychotherapy according to the treatment manual, sessions of 50 minutes twice per week
BEHAVIORALtreatment by experienced community psychotherapistsOutpatient psychotherapy in private practices or outpatient units of psychiatric hospitals. Licensed psychotherapists with experience and special interest in the treatment of borderline patients are treating according to the method they have learned.

Timeline

Start date
2004-10-01
Primary completion
2009-02-01
Completion
2015-02-01
First posted
2008-07-14
Last updated
2015-02-16
Results posted
2015-02-16

Locations

2 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT00714311. Inclusion in this directory is not an endorsement.